Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Wada

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Vaccine|July 29, 2010
Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patientsYu Mizote, Taku Taniguchi, Kei Tanaka, et al.
Psychiatry and Clinical Neurosciences|June 6, 2025
Closures of psychiatric units in general hospitals undermining progress in psychiatry: A stark contrast between Japan and the worldMichitaka Funayama, Yusuke Hasegawa, Naoko Satake, et al.
Vaccine|January 9, 2014
Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patientsYu Mizote, Akiko Uenaka, Midori Isobe, et al.
Journal for Immunotherapy of Cancer|April 15, 2024
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathwayMari Tone, Kota Iwahori, Michinari Hirata, et al.
Anticancer Research|April 30, 2022
Tumor-infiltrating ICOS<sup>+</sup> Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' TumorHitomi Kajikawa, Michinari Hirata, Miya Haruna, et al.
Scientific Reports|April 6, 2023
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapyChiaki Inagaki, Hisato Kawakami, Daichi Maeda, et al.
International Immunology|January 3, 2024
Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell functionYujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2026
Impact of PD-1<sup>+</sup>Tim-3<sup>+</sup>CD8<sup>+</sup> T cells in pretreatment tumors on chemotherapy responses in esophageal cancerTomoko Sumimoto, Kei Yamamoto, Takuro Saito, et al.
BJC Reports|November 8, 2024
C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancerYohei Nose, Takuro Saito, Yukinori Kurokawa, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Vaccine|July 29, 2010
Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patientsYu Mizote, Taku Taniguchi, Kei Tanaka, et al.
Psychiatry and Clinical Neurosciences|June 6, 2025
Closures of psychiatric units in general hospitals undermining progress in psychiatry: A stark contrast between Japan and the worldMichitaka Funayama, Yusuke Hasegawa, Naoko Satake, et al.
Vaccine|January 9, 2014
Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patientsYu Mizote, Akiko Uenaka, Midori Isobe, et al.
Journal for Immunotherapy of Cancer|April 15, 2024
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathwayMari Tone, Kota Iwahori, Michinari Hirata, et al.
Anticancer Research|April 30, 2022
Tumor-infiltrating ICOS<sup>+</sup> Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' TumorHitomi Kajikawa, Michinari Hirata, Miya Haruna, et al.
Scientific Reports|April 6, 2023
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapyChiaki Inagaki, Hisato Kawakami, Daichi Maeda, et al.
International Immunology|January 3, 2024
Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell functionYujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2026
Impact of PD-1<sup>+</sup>Tim-3<sup>+</sup>CD8<sup>+</sup> T cells in pretreatment tumors on chemotherapy responses in esophageal cancerTomoko Sumimoto, Kei Yamamoto, Takuro Saito, et al.
BJC Reports|November 8, 2024
C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancerYohei Nose, Takuro Saito, Yukinori Kurokawa, et al.
Pageof 10